Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Always arrives promptly
Injection site reactions are not unique to AOD 9604
Close follow-up helps manage dosage, side effect mitigation, and long-term planning
Pathobiology 1993
Care is delivered through a secure, HIPAA-compliant virtual healthcare model designed for long-term clinical partnership, and may include online health assessments, video consultations when clinically required, lab-informed reviews, metabolic monitoring, individualized treatment plans, and ongoing dose adjustments based on each patients medical history, treatment response, and licensed provider judgment
Indications: The primary clinical use is for the treatment of anemias caused by deficient red cell production (e.g., acquired or congenital aplastic anemia, myelofibrosis, and hypoplastic anemias)
US$ 28.24
US$ 23.80
US$ 22.84
US$ 26.65
